NasdaqGS - Nasdaq Real Time Price • USD
Pyxis Oncology, Inc. (PYXS)
As of 2:00 PM EDT. Market Open.
Major Holders
Breakdown | |
---|---|
20.49% | % of Shares Held by All Insider |
30.15% | % of Shares Held by Institutions |
37.92% | % of Float Held by Institutions |
64 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Laurion Capital Management, LP | 3.17M | Dec 31, 2023 | 5.45% | 13,967,387 |
Vanguard Group Inc | 1.31M | Dec 31, 2023 | 2.25% | 5,755,947 |
abrdn plc | 708.3k | Dec 31, 2023 | 1.22% | 3,120,074 |
Vestal Point Capital, LP | 440k | Dec 31, 2023 | 0.76% | 1,938,200 |
HHLR Advisors, LTD | 382.61k | Dec 31, 2023 | 0.66% | 1,685,379 |
Renaissance Technologies, LLC | 364.15k | Dec 31, 2023 | 0.63% | 1,604,080 |
Decheng Capital LLC | 326.81k | Dec 31, 2023 | 0.56% | 1,439,598 |
Geode Capital Management, LLC | 308.24k | Dec 31, 2023 | 0.53% | 1,357,801 |
Blackrock Inc. | 310.6k | Dec 31, 2023 | 0.53% | 1,368,184 |
Bridgeway Capital Management, Inc. | 236.19k | Dec 31, 2023 | 0.41% | 1,040,439 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Vanguard Total Stock Market Index Fund | 903.92k | Dec 31, 2023 | 1.55% | 3,981,781 |
abrdn Healthcare Investors | 481.65k | Dec 31, 2023 | 0.83% | 2,121,650 |
Vanguard Extended Market Index Fund | 385.42k | Dec 31, 2023 | 0.66% | 1,697,753 |
abrdn Life Sciences Investors | 226.66k | Dec 31, 2023 | 0.39% | 998,424 |
Fidelity Extended Market Index Fund | 178.16k | Jan 31, 2024 | 0.31% | 784,786 |
Bridgeway Funds Inc-Ultra Small Company Market Fund | 120.3k | Dec 31, 2023 | 0.21% | 529,899 |
Bridgeway Funds Inc-Ultra Small Company Fund | 115.9k | Dec 31, 2023 | 0.20% | 510,539 |
iShares Micro Cap ETF | 78.68k | Feb 29, 2024 | 0.14% | 346,594 |
Fidelity Total Market Index Fund | 50.54k | Jan 31, 2024 | 0.09% | 222,646 |
DFA U.S. Targeted Value Portfolio | 45.58k | Jan 31, 2024 | 0.08% | 200,771 |
Related Tickers
ELEV Elevation Oncology, Inc.
3.7100
+1.78%
LBPH Longboard Pharmaceuticals, Inc.
19.86
+3.17%
LRMR Larimar Therapeutics, Inc.
6.51
+2.84%
BCAB BioAtla, Inc.
2.4600
+9.33%
STRO Sutro Biopharma, Inc.
3.4850
+1.90%
MRUS Merus N.V.
45.06
+0.29%
CADL Candel Therapeutics, Inc.
6.35
-1.24%
VINC Vincerx Pharma, Inc.
0.8165
-8.94%
ELYM Eliem Therapeutics, Inc.
3.9900
+17.80%
NRIX Nurix Therapeutics, Inc.
12.47
+0.89%